Therefore, atypical splicing variants in sarcoglycan genes that can be easily missed by routine genetic testing should be excluded before establishing a genetic diagnosis of dystrophinopathy in patients with uncertain DMD missense variants and overlapping features with sarcoglycanopathies. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.